| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/06/1998 | US5705518 Method of activating photosensitive agents |
| 01/06/1998 | US5705514 Signal transduction inhibitor compounds |
| 01/06/1998 | US5705511 Fused pyrrolocarbazoles |
| 01/06/1998 | US5705508 Forming taxol derivatives |
| 01/06/1998 | US5705507 Aplha-substituted-3-benzyl-benzofurans |
| 01/06/1998 | US5705502 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 01/06/1998 | US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids |
| 01/06/1998 | US5705195 Drug delivery into blood for cardiovascular disorders |
| 01/06/1998 | US5705180 Therapeutic agent for the treatment of melanomas |
| 01/06/1998 | US5705177 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 01/06/1998 | US5705163 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 01/06/1998 | US5705159 Immunoreactive peptide sequence from a 43 KD human cancer antigen |
| 01/06/1998 | US5705156 Pseudomonas exotoxins binding to cells |
| 01/02/1998 | CA2206752A1 Benzothiophene compounds, intermediates, processes, and methods of use |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049818A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 12/31/1997 | WO1997049704A1 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 12/31/1997 | WO1997049702A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors |
| 12/31/1997 | WO1997049700A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 12/31/1997 | WO1997049689A1 Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors |
| 12/31/1997 | WO1997049432A1 Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin |
| 12/31/1997 | WO1997049428A1 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 12/31/1997 | WO1997049421A1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 12/31/1997 | WO1997049335A1 Novel radiopharmaceutical compositions and matrices and uses thereof |
| 12/31/1997 | WO1997044000A3 Dna-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents |
| 12/31/1997 | WO1997035873A3 Peptides with antiproliferative properties |
| 12/31/1997 | CN1169145A Novel farnesyl tranfering enzyme inhibitor, prepn. method and medicinal composition thereof |
| 12/31/1997 | CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen |
| 12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | CA2259222A1 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 12/31/1997 | CA2258608A1 Gm-csf administration for the treatment and prevention of recurrence of brain tumors |
| 12/30/1997 | USRE35706 Administering as viricides and antitumor agents |
| 12/30/1997 | US5703247 Anticarcinogenic agents |
| 12/30/1997 | US5703230 Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 12/30/1997 | US5703117 Hydrolysis-promoting hydrophobic taxane derivatives |
| 12/30/1997 | US5703109 Cyanophenyl-1,2,4-triazole derivative |
| 12/30/1997 | US5703095 Prevention ferritin from releasing oxygen |
| 12/30/1997 | US5703092 Hydroxamic acid compounds as metalloprotease and TNF inhibitors |
| 12/30/1997 | US5703090 Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 12/30/1997 | US5703080 Method for stabilizing duocarmycin derivatives |
| 12/30/1997 | US5703054 Oligonucleotide modulation of protein kinase C |
| 12/30/1997 | US5703050 Inhibit platelet aggregation, metastasis of carcinoma cells, osteoclast binding to bone surface |
| 12/30/1997 | US5703039 Chimeric toxins |
| 12/30/1997 | US5703038 Emhanced biological activity |
| 12/30/1997 | US5702890 Inhibitors of alternative alleles of genes as a basis for cancer therapeutic agents |
| 12/30/1997 | US5702752 Production of isoflavone enriched fractions from soy protein extracts |
| 12/30/1997 | US5702728 Analgesics; antitumor agents |
| 12/30/1997 | US5702698 Promoting production of colony stimulating factor |
| 12/29/1997 | EP0814154A2 Recombinant alphavirus vectors |
| 12/29/1997 | EP0814077A1 Benzoylguanidines, process for their preparation and medicaments containing them |
| 12/29/1997 | EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices |
| 12/29/1997 | EP0813872A1 Berberine derivates for inhibiting hsp27 production |
| 12/29/1997 | EP0813545A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 12/29/1997 | EP0813544A1 Bradykinin antagonist peptides incorporating n-substituted glycines |
| 12/29/1997 | EP0813539A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom |
| 12/29/1997 | EP0813535A1 Hexacyclic camptothecin analogues, and process for preparing them |
| 12/29/1997 | EP0813531A1 Antitumour isocoumarins |
| 12/29/1997 | EP0813520A1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/29/1997 | EP0813423A1 Composition to ameliorate osteolysis and metastasis |
| 12/29/1997 | EP0813419A1 Modulators of regulatory proteins |
| 12/29/1997 | EP0705270B1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 12/29/1997 | EP0552296B1 Mouse monoclonal antibodies |
| 12/24/1997 | WO1997048805A1 HUMAN THYMOSIN β15 GENE, PROTEIN AND USES THEREOF |
| 12/24/1997 | WO1997048804A2 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 12/24/1997 | WO1997048803A1 Human protein kinase c inhibitor homolog |
| 12/24/1997 | WO1997048799A2 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | WO1997048697A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
| 12/24/1997 | WO1997048696A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 12/24/1997 | WO1997048695A1 New pyridyl alkane acid amides as cytostatics and immunosuppressives |
| 12/24/1997 | WO1997048691A1 Ring-fused dihydropyranes, process for the preparation and use thereof |
| 12/24/1997 | WO1997048400A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048399A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | WO1997048368A2 Naphthyridines which affect il-4 and g-csf |
| 12/24/1997 | WO1997041230A3 Cc-type chemokines |
| 12/24/1997 | WO1997040073A3 Biologically active protein (collagen fragment hf-coll-18/514cf) for inhibiting the growth of tumours and capillary profilerations |
| 12/24/1997 | WO1997040006A3 Phosphate mimics |
| 12/24/1997 | WO1997036497A3 Cocoa extract compounds and methods for making and using the same |
| 12/24/1997 | CN1168699A Protein kinase NPK-llo |
| 12/24/1997 | CN1168696A RNA component of telomerase |
| 12/24/1997 | CN1168695A Inhibitor of stem cell proliferation and uses thereof |
| 12/24/1997 | CN1168633A Boronic ester and acid compounds, synthesis and uses |
| 12/24/1997 | CN1168632A Antineoplastic cocoa extracts, method for making, using |
| 12/24/1997 | CN1168631A Methods for treating resistant tumors |
| 12/24/1997 | CN1168278A Antineoplastic Chinese medicine prepn and its prepn process |
| 12/24/1997 | CN1036779C Aryl naphthenes derivant and its use |
| 12/24/1997 | CA2258589A1 Certain phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258587A1 Hydroxy-phosphinyl derivatives useful as naaladase inhibitors |
| 12/24/1997 | CA2258526A1 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 12/24/1997 | CA2257855A1 Human thymosin .beta.15 gene, protein and uses thereof |
| 12/24/1997 | CA2257847A1 Polynucleotides from human fetal brain encoding secreted proteins |
| 12/24/1997 | CA2257528A1 Human protein kinase c inhibitor homolog |
| 12/23/1997 | US5700922 PNA-DNA-PNA chimeric macromolecules |
| 12/23/1997 | US5700911 Bone morphogenetic protein -11 (BMP-11) compositions |
| 12/23/1997 | US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 12/23/1997 | US5700830 Prevention adhesion of cancerous cells and noncancerous structures in mammals |
| 12/23/1997 | US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 12/23/1997 | US5700825 Used to kill hypoxic tumor cells |
| 12/23/1997 | US5700821 Inhibit cell proliferation |
| 12/23/1997 | US5700816 Antiarthritic agents |
| 12/23/1997 | US5700811 Potent inducers of terminal differentiation and method of use thereof |